In an large-scale review recently published in Cephalalgia, researchers found that a broader range of blood pressure (BP) medications could be leveraged more efficiently than currently practiced to prevent migraines. The study underlines the untapped potential of these common and cost-effective drugs in migraine prevention, a condition affecting up to 1 billion people worldwide.